IP Library Granted Patent US 7,300,755
Granted Patent B1
US 7,300,755 · App. 10/843,985 · Granted Nov 27, 2007

Methods for haplotyping genomic DNA

Assignees: Fred Hutchinson Cancer Research Center; Institute for Systems Biology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,300,755
App. No.
10/843,985
Granted
Nov 27, 2007
Kind
B1
Abstract

The present invention provides a novel method for specifically isolating and separating large segments of genomic DNA that can subsequently be used to determine a genomic haplotype. The invention relies on using a solid phase having a flat surface arrayed with oligonucleotides designed to specifically hybridize to each particular haplotype of an individual sample, e.g., oligonucleotides designed to specifically hybridize with each of the two HLA-B haplotypes, HLA-A, HLA-C, HLA-DR, HLA-DQ, and the like. The genomic DNA is contacted and hybridized to the arrayed oligonucleotides to form a genomic DNA/oligonucleotide complex. The excess genomic DNA is washed away and the haplotype separated genomic DNA is denatured from the oligonucleotide probe and collected. The method of the present invention allows for the separation of genomic DNA fragments of between approximately 2 to about 4 megabases (Mb). Separation of the haplotypes of large genomic DNA fragments allows for linkage analysis of other HLA alleles and polymorphisms, microsatellite, SNPs, and the like across a large span of the HLA region, including HLA-A, -B, -C, and HLA-DRB1 regions. This linkage analysis is particularly useful when HLA typing for an individual with limited family HLA typing available.

Claims (21)

1. A method for separating large fragments of genomic DNA by haplotype, comprising:

(a) providing a flat solid surface comprising covalently bound oligonucleotide probes having a nucleotide sequence complementary to each haplotype of an HLA allele;

(b) contacting the oligonucleotide probes with a sample of genomic DNA under conditions conducive to specific hybridization of the genomic DNA to the oligonucleotide probes to form a genomic DNA/oligonucleotide complex;

(c) removing excess genomic DNA;

(d) denaturing the genomic DNA/oligonucleotide complex; and

(e) separately collecting the genomic DNA corresponding to each haplotype;

thereby separating the large fragments of genomic DNA by haplotype.

2. The method according to claim 1 , wherein the HLA allele is an HLA-B allele.

3. The method according to claim 1 , wherein the oligonucleotide probes are about 20 to about 40 bases in length.

4. The method according to claim 1 , wherein the oligonucleotide probes are spaced to allow independent manipulation of the genomic DNA hybridized to each probe.

5. The method of claim 1 , wherein the hybridization is carried out at a temperature of less than 30 degrees Celsius for 3 hours or more.

6. The method according to claim 1 , wherein said large fragments of genomic DNA have a length of 2 megabases (Mb) to 4 megabases (Mb).

7. The method according to claim 1 , wherein the solid surface comprises glass.

8. The method according to claim 1 , wherein the solid surface comprises a glass slide.

9. The method according to claim 1 , wherein the solid surface has been derivatized with a vapor phase deposition of an aminoalkyltrialkoxysilane.

10. The method according to claim 9 , wherein the aminoaklyltrialkoxysilane is 3-aminopropyltrimethoxylsilane.

11. The method according to claim 1 , wherein the HLA allele is an HLA-A allele.

12. The method according to claim 1 , wherein the HLA allele is selected from the group consisting of an HLA-C allele, an HLA-DR allele, and HLA-DQ allele, and an HLA-DP allele.

13. The method according to claim 1 , wherein said covalently bound oligonucleotide probes further comprise a linking group, and wherein said linking group is sufficient to provide optimum binding of said fragments of genomic DNA to said oligonucleotide probes.

14. The method according to claim 1 , wherein said removing step is carried out by washing with buffer.

15. The method according to claim 14 , wherein said linking group is a poly dT spacer.

Assignments (5)
CONFIRMATORY LICENSE Recorded Aug 12, 2013
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031003/0708 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 9, 2008
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021210/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2005
From: GUO, ZHEN
To: INSTITUTE FOR SYSTEMS BIOLOGY
Reel/Frame 015713/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2005
From: HOOD, LEROY
To: INSTITUTE FOR SYSTEMS BIOLOGY
Reel/Frame 015713/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2005
From: PETERSDORF, EFFIE W.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 015690/0054 →
Continuity (1)
Provisional Application 6047032200 · May 12, 2003